Comments
Loading...

Relmada Therapeutics

RLMDNASDAQ
Logo brought to you by Benzinga Data
$2.80
0.051.82%
At close: -
$2.85
0.051.79%
After Hours: Nov 20, 4:02 PM EDT

Relmada Therapeutics (NASDAQ:RLMD) Stock, Earnings Estimates, EPS, And Revenue

Relmada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS
$-0.720
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Relmada Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Relmada Therapeutics (RLMD) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-07$-0.72$-0.64-12.5 %
Jun 20242024-08-07$-0.59$-0.8328.9 %
Mar 20242024-05-08$-0.72$-0.8818.2 %
Dec 20232024-03-19$-0.84$-0.83-1.20 %

Relmada Therapeutics (RLMD) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?

A

Relmada Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Relmada Therapeutics (NASDAQ:RLMD)?

A

Relmada Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.72, which missed the estimate of $-0.64.

Q

What were Relmada Therapeutics’s (NASDAQ:RLMD) revenues?

A

Relmada Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch